Journal: Drug Design, Development and Therapy
Article Title: Rhein Alleviates Cisplatin-Induced Acute Kidney Injury via Downregulation of NOX4-COX2/PGFS Signaling Pathway
doi: 10.2147/DDDT.S515409
Figure Lengend Snippet: Rhein reduces CDDP-induced nephrotoxicity without affecting the antitumor efficacy. CDDP (10μg/mL)-treated human non-small-cell lung cancer (NSCLC) A549 cells were incubated with 40 μM Rhein for 24 h. ( A ) The cell viability was determined by the CCK8 analysis (n=6). ( B ) The CDDP-sensitive Lewis lung carcinoma (LLC) cells (2×10 5 ) were inoculated subcutaneously into C57BL/6 mice for 14 days, and the mice were treated with CDDP alone (4 mg/kg, the drugs were administered every other day for 10 days, resulting in an accumulative dose of 20 mg/kg) or combination with Rhein (80mg/kg, the drugs were administered 1 hour after CDDP injection). ( C and D ) The xenograft tumor weights and tumor volume of C57BL/6 mice injected subcutaneously with LLC cells with the treatment of CDDP, Rhein alone or in combination with Rhein (n=5). Data are shown as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001: CDDP vs Control. ## P < 0.01 CDDP+Rhein vs CDDP.
Article Snippet: To determine whether Rhein might affect the anti-tumor activity of CDDP in vitro, CDDP-sensitive human non-small-cell lung cancer (NSCLC) cell line A549 (catalog no. CCL-185, RRID: CVCL_0023; ATCC, Manassas, VA, USA) was exposed to CDDP (10 μg/mL) alone or in combination with Rhein for 24h, cell viability was then measured.
Techniques: Incubation, Injection, Control